A phase II study of sunitinib as a second-line treatment in advanced biliary tract carcinoma: A multicentre, multinational study

by Jun Ho Yi, Sumitra Thongprasert, Jeeyun Lee, D. C. Doval, Se Hoon Park, Joon Oh Park, Young Suk Park, Won Ki Kang, Ho Yeong Lim
Published 2018